Celebrating 20 years
Brain imaging abnormalities and outcome after acute ischaemic stroke: the ENCHANTED trial
Building back better after COVID-19: The research agenda
The wider benefits of SGLT2 inhibitors
Principal Director of The George Institute, Professor Stephen MacMahon, talking at an Australian Academy of Science event about why frugal healthcare innovation should be a global research priority.